N-[[(3S)-1-(5-Chloro-2-methoxybenzoyl)-3-piperidinyl]methyl]ethenesulfonamide manufacturers
- Kras4B G12D-IN-1
-
- $93.00
-
2026-05-11
- CAS:2042365-85-3
- Purity: 99.90%
- Supply Ability: 10g
|
| | N-[[(3S)-1-(5-Chloro-2-methoxybenzoyl)-3-piperidinyl]methyl]ethenesulfonamide Basic information |
| | N-[[(3S)-1-(5-Chloro-2-methoxybenzoyl)-3-piperidinyl]methyl]ethenesulfonamide Chemical Properties |
| Boiling point | 558.0±60.0 °C(Predicted) | | density | 1.287±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(Predicted) | | pka | 10.42±0.40(Predicted) | | form | Solid | | color | White to off-white |
| | N-[[(3S)-1-(5-Chloro-2-methoxybenzoyl)-3-piperidinyl]methyl]ethenesulfonamide Usage And Synthesis |
| Uses | Kras4B G12D-IN-1 is a Kras4B G12D inhibitor with anticancer effects. Kras4B G12D-IN-1 decreases Kras protein expression in mouse embryonic fibroblasts (MEF) expressing Kras4B G12D (WO2016179558A1, Comp 994566)[1]. | | IC 50 | KRas G12D | | References | [1] Frank Mccormick, et al. K-ras modulators. WO2016179558A . |
| | N-[[(3S)-1-(5-Chloro-2-methoxybenzoyl)-3-piperidinyl]methyl]ethenesulfonamide Preparation Products And Raw materials |
|